These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37279375)

  • 21. Bacterial FtsZ inhibition by benzo[
    Dhameliya TM; Tiwari R; Patel KI; Vagolu SK; Panda D; Sriram D; Chakraborti AK
    Future Med Chem; 2022 Oct; 14(19):1361-1373. PubMed ID: 36103222
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and Antimycobacterial Activity of 2,5-Disubstituted and 1,2,5-Trisubstituted Benzimidazoles.
    Jiménez-Juárez R; Cruz-Chávez W; de Jesús-Ramírez N; Castro-Ramírez GI; Uribe-González I; Martínez-Mejía G; Ruiz-Nicolás R; Aguirre-Alvarado C; Castrejón-Jiménez NS; García-Pérez BE
    Front Chem; 2020; 8():433. PubMed ID: 32656177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
    Nayak N; Ramprasad J; Dalimba U
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.
    Krishna VS; Zheng S; Rekha EM; Nallangi R; Sai Prasad DV; George SE; Guddat LW; Sriram D
    Eur J Med Chem; 2020 May; 193():112178. PubMed ID: 32171154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.
    Karunanidhi S; Chandrasekaran B; Karpoormath R; Patel HM; Kayamba F; Merugu SR; Kumar V; Dhawan S; Kushwaha B; Mahlalela MC
    Bioorg Chem; 2021 Oct; 115():105133. PubMed ID: 34329993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of anti-TB agents that target the cell-division protein FtsZ.
    Kumar K; Awasthi D; Berger WT; Tonge PJ; Slayden RA; Ojima I
    Future Med Chem; 2010 Aug; 2(8):1305-23. PubMed ID: 21339840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity.
    Veau D; Krykun S; Mori G; Orena BS; Pasca MR; Frongia C; Lobjois V; Chassaing S; Lherbet C; Baltas M
    ChemMedChem; 2016 May; 11(10):1078-89. PubMed ID: 27097919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.
    Kumar K; Awasthi D; Lee SY; Zanardi I; Ruzsicska B; Knudson S; Tonge PJ; Slayden RA; Ojima I
    J Med Chem; 2011 Jan; 54(1):374-81. PubMed ID: 21126020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation.
    Jiang Y; Qian A; Li Y
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonhydrolyzable d‑phenylalanine-benzoxazole derivatives retain antitubercular activity.
    Pepi MJ; Chacko S; Kopetz N; Boshoff HIM; Cuny GD; Hedstrom L
    Bioorg Med Chem Lett; 2023 Jan; 80():129116. PubMed ID: 36572353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microwave-assisted organic synthesis, antimycobacterial activity, structure-activity relationship and molecular docking studies of some novel indole-oxadiazole hybrids.
    Desai NC; Somani HC; Mehta HK; Jadeja DJ; Khasiya AG; Khedkar VM
    SAR QSAR Environ Res; 2022 Feb; 33(2):89-109. PubMed ID: 35102805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 2-Nitroimidazole and Imidazooxazole Derivatives and their Activity against Trypanosoma cruzi and Mycobacterium tuberculosis.
    Faria JV; Passos FPZ; da Costa PHA; de Oliveira AP; Cruz YODD; Castelo-Branco FS; Lourenço MCS; Murta SMF; Junior PAS; Bernardino AMR; Bastos MM; Boechat N
    Med Chem; 2022; 18(6):701-709. PubMed ID: 34784878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational studies of the properties and activities of selected trisubstituted benzimidazoles as potential antitubercular drugs inhibiting MTB-FtsZ polymerization.
    Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
    J Biomol Struct Dyn; 2022 Mar; 40(4):1558-1570. PubMed ID: 33021149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
    Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
    Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.
    Dongamanti A; Aamate VK; Devulapally MG; Gundu S; Balabadra S; Manga V; Yogeeswari P; Sriram D; Balasubramanian S
    Mol Divers; 2017 Nov; 21(4):999-1010. PubMed ID: 28840414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations.
    Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
    Tuberculosis (Edinb); 2020 Mar; 121():101920. PubMed ID: 32279872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
    Rashmi P; Nargund LV; Hazra K; Chandra JN
    Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of antimycobacterial activity of riboflavin derivatives.
    Harale B; Kidwai S; Ojha D; Singh M; Chouhan DK; Singh R; Khedkar V; Rode AB
    Bioorg Med Chem Lett; 2021 Sep; 48():128236. PubMed ID: 34242760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.